Mimedx (MDXG) Income from Continuing Operations (2011 - 2026)

Mimedx (MDXG) has 16 years of Income from Continuing Operations data on file, last reported at 10860000.0 in Q1 2026.

• For the quarter ending Q1 2026, Income from Continuing Operations fell 254.63% year-over-year to 10860000.0; the trailing twelve-month figure through Mar 2026 stood at 30697000.0 (down 23.18% YoY), and the FY2025 full-year result was 48578000.0, up 15.67% from the prior year.
• Income from Continuing Operations declined to 10860000.0 in Q1 2026, from 15191000.0 in the prior quarter.
• In the past five years, Income from Continuing Operations ranged from a high of 51288000.0 in Q4 2023 to a low of 10868000.0 in Q2 2022.
• A 5-year average of 7482588.24 and a median of 8842000.0 in 2023 frame the typical range for Income from Continuing Operations.
• Peak annual rise in Income from Continuing Operations reached 4839.7% in 2022, while the deepest fall reached 510.91% in 2022.
• Tracing MDXG's Income from Continuing Operations over 5 years: stood at 9830000.0 in 2022, then jumped by 421.75% to 51288000.0 in 2023, then slumped by 85.5% to 7438000.0 in 2024, then jumped by 104.24% to 15191000.0 in 2025, then sank by 171.49% to 10860000.0 in 2026.
• Business Quant data shows MDXG's Income from Continuing Operations at 10860000.0 in Q1 2026, 15191000.0 in Q4 2025, and 16748000.0 in Q3 2025.